These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Generation of two induced pluripotent stem cell (iPSC) lines (BBANTWi006-A, BBANTWi007-A) from Brugada syndrome patients carrying an SCN5A mutation. Simons E; Nijak A; Loeys B; Alaerts M Stem Cell Res; 2022 Apr; 60():102719. PubMed ID: 35247843 [TBL] [Abstract][Full Text] [Related]
11. Generation of an induced pluripotent stem cell line from a Brugada syndrome patient carrying SCN5A/c.3118G>C mutation. Fan H; Su J; Wang X; Wang H; Chen X; Sun Y; Jiang C; Liang P Stem Cell Res; 2024 Oct; 80():103529. PubMed ID: 39121653 [TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation. Hong L; Zhang M; Ly OT; Chen H; Sridhar A; Lambers E; Chalazan B; Youn SW; Maienschein-Cline M; Feferman L; Ong SG; Wu JC; Rehman J; Darbar D Stem Cell Reports; 2021 Jun; 16(6):1542-1554. PubMed ID: 34019817 [TBL] [Abstract][Full Text] [Related]
13. Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. Hayano M; Makiyama T; Kamakura T; Watanabe H; Sasaki K; Funakoshi S; Wuriyanghai Y; Nishiuchi S; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Yokoi F; Chen J; Baba O; Horie T; Chonabayashi K; Ohno S; Toyoda F; Yoshida Y; Ono K; Horie M; Kimura T Circ J; 2017 Nov; 81(12):1783-1791. PubMed ID: 28637969 [TBL] [Abstract][Full Text] [Related]
14. Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A). Kayser A; Dittmann S; Hamidi J; Laufer SD; Krampe R; Mearini G; Hansen A; Schulze-Bahr E Stem Cell Res; 2024 Aug; 78():103446. PubMed ID: 38776645 [TBL] [Abstract][Full Text] [Related]
15. The G213D variant in Nav1.5 alters sodium current and causes an arrhythmogenic phenotype resulting in a multifocal ectopic Purkinje-related premature contraction phenotype in human-induced pluripotent stem cell-derived cardiomyocytes. Calloe K; Geryk M; Freude K; Treat JA; Vold VA; Frederiksen HRS; Broendberg AK; Frederiksen TC; Jensen HK; Cordeiro JM Europace; 2022 Dec; 24(12):2015-2027. PubMed ID: 35726875 [TBL] [Abstract][Full Text] [Related]
16. The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy. Salvarani N; Crasto S; Miragoli M; Bertero A; Paulis M; Kunderfranco P; Serio S; Forni A; Lucarelli C; Dal Ferro M; Larcher V; Sinagra G; Vezzoni P; Murry CE; Faggian G; Condorelli G; Di Pasquale E Nat Commun; 2019 May; 10(1):2267. PubMed ID: 31118417 [TBL] [Abstract][Full Text] [Related]
17. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes. Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504 [TBL] [Abstract][Full Text] [Related]
18. Generation of four induced pluripotent stem cell lines from a family harboring a single nucleotide variant in SCN5A. Martínez-Moreno R; Carreras D; Aran B; Kuebler B; Sarquella-Brugada G; Brugada R; Pérez GJ; Scornik FS; Selga E Stem Cell Res; 2022 Aug; 63():102847. PubMed ID: 35772296 [TBL] [Abstract][Full Text] [Related]